| mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
5e-13 |
| mRNA |
ruxolitinib |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
7e-09 |
| mRNA |
ML239 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
Imatinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
8e-07 |
| mRNA |
dexamethasone |
CTRPv2 |
pan-cancer |
AAC |
-0.16 |
3e-06 |
| mRNA |
PD318088 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
3e-06 |
| mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
1e-05 |
| mRNA |
prima-1 |
CTRPv2 |
pan-cancer |
AAC |
-0.14 |
3e-05 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
3e-05 |
| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
5e-05 |